Amit Hasija - Net Worth and Insider Trading

Amit Hasija Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amit Hasija owns 1 companies in total, including Milestone Pharmaceuticals Inc (MIST) .

Click here to see the complete history of Amit Hasija’s form 4 insider trades.

Insider Ownership Summary of Amit Hasija

Ticker	Comapny	Transaction Date	Type of Owner
MIST	Milestone Pharmaceuticals Inc	2019-09-09	CFO & EVP of Corp. Development

Amit Hasija Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Amit Hasija Ownership Network

Ownership Network List of Amit Hasija

No Data

Ownership Network Relation of Amit Hasija

Amit Hasija Owned Company Details

What does Milestone Pharmaceuticals Inc do?

Who are the key executives at Milestone Pharmaceuticals Inc?

Amit Hasija is the CFO & EVP of Corp. Development of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .

Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary

Over the past 18 months, Amit Hasija made no insider transaction in Milestone Pharmaceuticals Inc (MIST). Other recent insider transactions involving Milestone Pharmaceuticals Inc (MIST) include a net purchase of 10,000 shares made by David Bharucha ,

In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.

Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Milestone Pharmaceuticals Inc Insider Transactions

No Available Data

Amit Hasija Mailing Address

Above is the net worth, insider trading, and ownership report for Amit Hasija. You might contact Amit Hasija via mailing address: C/o Milestone Pharmaceuticals Inc., 1111 Dr. Frederik-philips Blvd, Ste 420, Montreal A8 H4m 2x6.

Discussions on Amit Hasija

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.